Mycobacterium paragordonae: Insights into its Research Progress and Potential Applications

Mycobacterium paragordonae (Mpg), a species first identified in 2014, has gained increasing attention due to its unique characteristics and potential applications.This comprehensive review summarizes current research on Mpg, focusing on its discovery, pathogenicity, antibiotic susceptibility, vaccine potential, and environmental adaptability.Mpg has shown significant promise as a vaccine candidate, demonstrating strong immune responses and safety in mouse models.It retains the RD1 region, absent in BCG, enhancing its vaccine potential against Mycobacterium tuberculosis, compared to BCG.Mpg also exhibits heterologous immunity and can serve as a recombinant vaccine vector, potentially offering a platform for various diseases, including tuberculosis and cancer.Additionally, the environmental adaptability of Mpg, particularly in aquatic systems, and its clinical implications are discussed.Although Mpg infections in humans are rare, documented cases emphasize the need for accurate diagnosis and appropriate treatment.This review highlights Mpg's versatility and potential as a significant tool in vaccine development and immunotherapy, warranting further research and clinical trials.